Catherine E Arnold
Deceased
from Greenbelt, MD
- Also known as:
-
- Catherine Elzabeth Arnold
- Catherine E Alfred
- Catherine A Alfred
- Catherine A Bamidele
- Catherine Arnoldalfred
- Alfred Catherine Arnold
- Catherine D
- Katherine Arnold
Catherine Arnold Phones & Addresses
- Greenbelt, MD
- Washington, DC
- District Heights, MD
- Lanham, MD
- Bladensburg, MD
- Hyattsville, MD
- Suitland, MD
License Records
Catherine Loulie Arnold
Address:
Washington, DC
License #:
RN15833 - Expired
Category:
NURSING
Issued Date:
Aug 1, 1951
Expiration Date:
Jun 30, 1952
Type:
REGISTERED NURSE
Wikipedia References
Catherine Arnold
Plaxo
Catherine Arnold
view sourceTumwater, WAArtist / Designer at ProlificPortfolio In my professional life, I have created logo designs, signs, and artwork. I've recently developed a website, showing my artwork and offering instant... In my professional life, I have created logo designs, signs, and artwork. I've recently developed a website, showing my artwork and offering instant downloadable artwork.
Googleplus
Catherine Arnold
Work:
Always self employed
Education:
North Toronto, Thorton Hall
Relationship:
Married
Catherine Arnold
Catherine Arnold
Catherine Arnold
Catherine Arnold
Catherine Arnold
Catherine Arnold
Catherine Arnold
Youtube
News
Pfizer Profit Matches Analyst Estimates as It Narrows Forecast
view source- ofacitinib could sell $2.16 billion by 2017, according tothe average of three analyst estimates compiled Bloomberg.Eliquis, meanwhile, could generate $5.2 billion in sales by2020, which will be split with Bristol-Myers, Catherine Arnold,an analyst with Credit Suisse Group AG, said in a note toclients.
- Date: Nov 01, 2012
- Category: Business
- Source: Google
Abbott's Hepatitis C Drugs Clear Virus in 99% of Patients
view source- Bristol-Myers and Abbott could cut into a market thatGilead had been expected to dominate, said Catherine Arnold, ananalyst with Credit Suisse Group AG in New York. In a note toclients today, she predicted that Gilead would have $3.8 billionin hepatitis C sales in 2020, and Abbott would follow w
- Date: Oct 17, 2012
- Category: Business
- Source: Google
Merck Profit Tops Estimates as Sales of Diabetes Drugs Grow
view source- Maintaining the full-year forecast and beating analystestimates this quarter is a boost for the company, given thecurrency trends, said Catherine Arnold, an analyst with CreditSuisse Group AG in New York.
- Date: Jul 27, 2012
- Category: Business
- Source: Google
Lilly takes aim at blockbuster Lantus with promising PhII diabetes drug data
view source- that at least two analysts were keeping their enthusiasm in check. Credit Suisse analyst Catherine Arnold noted that if the big pharma partners can prove the treatment is safe and continue to edge out Lantus, this experimental therapy would easily be able to break the $1 billion blockbuster sales mark.
- Date: Jun 12, 2012
- Category: Health
- Source: Google
Rheumatoid Arthritis Drugs Square Off Against Humira
view source- with other new data including a Bristol-Myers Squibb Co. finding that its arthritis treatment Orencia is comparable to Humira, raise the prospect of slowing Humira growth, wrote Credit Suisse stock analyst Catherine Arnold in a note earlier this week, when abstracts of the studies were released. S
- Date: Jun 08, 2012
- Category: Health
- Source: Google
Pfizer's Prevnar 13 Shot Wins US Approval for Older Adults
view source- the first nine months of 2011, according to the regulatory filings from Pfizer, the worlds biggest drugmaker. The vaccine may generate $5.9 billion by 2015, with adult use contributing $1.8 billion, said Catherine Arnold, an analyst with Credit Suisse Group AG in New York, in a note to investors.
- Date: Dec 31, 2011
- Category: Health
- Source: Google
Abbott Spinoff May Fetch $54 Billion as Humira Tempts Rivals
view source- Catherine Arnold, a drug industry analyst with Credit Suisse in New York, said the price tag may be held down by doubts about Humiras potential successors within the Abbott pipeline. Candidates like bardoxolone, for chronic kidney disease, still arent proven, she said in a note to clients.
- Date: Oct 20, 2011
- Category: Business
- Source: Google
Pfizer's Arthritis Pill Tofacitinib Matches Abbott's Shot in Final Studies
view source- rket, ledby Humira from Abbott Park, Illinois-based Abbott, Johnson &Johnson (JNJ)s Remicade and Amgen Inc. (AMGN)s Enbrel, which New York-basedPfizer shares. The new drug may bring in more than $2.6 billiona year, said Catherine Arnold, an analyst at Credit Suisse GroupAG in New York.
- Date: Sep 09, 2011
- Category: Health
- Source: Google
Myspace
Catherine Arnold
view sourceGet Report for Catherine E Arnold from Greenbelt, MDDeceased